According to Syndicate Market Research, the global Automated Breast Ultrasound Systems (ABUS) Market hit about USD 2.21 billion in 2024. The Automated Breast Ultrasound Systems (ABUS) Market industry is expected to reach around USD 2.52 billion in 2025 and a whopping USD 10.11 billion by 2034, growing at a steady compound annual growth rate (CAGR) of roughly 16.7% from 2026 to 2034. The report analyzes the Automated Breast Ultrasound Systems (ABUS) Market's drivers, restraints, and the impact it has on demand during the forecast period. Furthermore, it will assist in navigating and exploring emerging market prospects.
Automated Breast Ultrasound Systems (ABUS) are advanced, operator-independent imaging devices designed to capture high-resolution three-dimensional ultrasound images of the entire breast, serving as a critical adjunct to mammography for women with dense breast tissue where traditional mammograms often fail to detect cancers effectively. These systems automate the scanning process to ensure consistent, reproducible results with minimal user variability, enabling earlier detection of breast abnormalities, reduced false negatives, and improved diagnostic accuracy in both screening and diagnostic settings. ABUS technology integrates seamlessly into clinical workflows and is increasingly enhanced with artificial intelligence for lesion detection and risk assessment.
The market is propelled by the rising global incidence of breast cancer, growing awareness of the limitations of mammography in dense breasts, and supportive legislation mandating supplemental screening, alongside rapid technological advancements in 3D imaging and AI integration. Key growth drivers include expanding healthcare infrastructure in emerging economies and demand for non-ionizing, radiation-free diagnostics, while restraints arise from high initial equipment costs and the need for specialized training. Emerging trends encompass AI-powered automated lesion analysis, portable ABUS devices for point-of-care use, and integration with multimodal imaging platforms for personalized breast care.
Growth Drivers
The global surge in breast cancer cases, particularly among women with dense breast tissue where mammography sensitivity drops below 50%, is accelerating demand for ABUS as a complementary screening tool that improves detection rates by up to 30% without radiation exposure.
Supportive regulatory policies and awareness campaigns by governments and NGOs in developed and emerging markets are further fueling adoption, as they mandate supplemental ultrasound screening and promote early-stage diagnosis to improve survival outcomes.
Restraints
The substantial upfront cost of ABUS equipment, often exceeding several hundred thousand dollars per unit, poses a significant barrier for smaller clinics and facilities in cost-sensitive regions, limiting widespread penetration despite long-term clinical benefits.
Shortage of trained radiologists and sonographers proficient in interpreting 3D ABUS images requires extensive training programs, slowing workflow integration and creating operational challenges in under-resourced healthcare settings.
Opportunities
Incorporation of artificial intelligence for automated lesion detection and risk stratification presents lucrative opportunities to enhance diagnostic precision, reduce reading time by up to 50%, and enable remote expert consultations in underserved areas.
Rapid healthcare infrastructure development in Asia-Pacific and Latin America, combined with increasing private investments in women’s health, offers vast untapped potential for ABUS deployment in population-based screening programs.
Challenges
Inconsistent reimbursement policies for ABUS procedures across regions create financial uncertainty for providers, hindering adoption despite proven clinical efficacy compared to traditional handheld ultrasound.
Intense competition from evolving alternatives such as contrast-enhanced mammography and MRI, which offer higher sensitivity in select cases, pressures manufacturers to continuously innovate and demonstrate superior cost-effectiveness.
| Report Attributes | Report Details |
|---|---|
| Report Name | Automated Breast Ultrasound Systems (ABUS) Market |
| Market Size in 2024 | USD 2.21 Billion |
| Market Size in 2025 | USD 2.52 Billion |
| Market Forecast in 2034 | USD 10.11 Billion |
| Growth Rate (2026-2034) | CAGR of 16.7% |
| Base Year | 2025 |
| Historical Year | 2020 - 2024 |
| Forecast Year | 2026 - 2034 |
| Number of Pages | 235 |
| Report Coverage | Revenue Forecast, Market Dynamics, Company Profile, Competitive Landscape, Recent Developments, Growth Factors, and Recent Trends |
| Key Companies Covered | GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Hologic Inc., SonoCine Inc., Delphinus Medical Technologies Inc., Canon Medical Systems Corporation, Hitachi Ltd., QT Imaging, Inc., and ALPINION Medical Systems Co. Ltd. |
| Segments Covered | By Product Type, By Application, By End-User, and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, and The Middle East and Africa (MEA) |
| Customization Scope | Customization for Segments, Region, Country-level will be provided. Avail customized purchase options to meet your exact research needs. Request For Customization |
The Automated Breast Ultrasound Systems (ABUS) Market is segmented by product type, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2026 to 2034.
Based on Product Type Segment, the Automated Breast Ultrasound Systems (ABUS) Market is divided into Automated Breast Volume Scanner, Automated Breast Ultrasound System, and others. Automated Breast Volume Scanner is the most dominant segment due to its ability to generate standardized 3D volumetric images that cover the entire breast in a single scan, significantly improving cancer detection in dense tissue and reducing operator dependency, which drives market growth by enabling efficient large-scale screening programs and higher diagnostic confidence among radiologists. Automated Breast Ultrasound System ranks as the second most dominant segment, offering real-time 2D/3D hybrid capabilities that support dynamic assessments and complement screening workflows, thereby accelerating overall market expansion through versatility in both screening and diagnostic applications.
Based on Application Segment, the Automated Breast Ultrasound Systems (ABUS) Market is divided into Breast Cancer Screening, Diagnostic Imaging, Pre-operative Evaluation, and others. Breast Cancer Screening is the most dominant segment as ABUS serves as an essential supplemental tool for women with dense breasts, where it detects additional cancers missed by mammography and supports population-level early detection initiatives mandated by legislation, directly propelling market demand through increased procedure volumes and improved patient outcomes. Diagnostic Imaging is the second most dominant segment, leveraging ABUS for detailed characterization of suspicious lesions identified in initial screenings, which enhances biopsy accuracy and treatment planning while contributing to sustained revenue growth in specialized oncology settings.
Based on End-User Segment, the Automated Breast Ultrasound Systems (ABUS) Market is divided into Hospitals & Clinics, Diagnostic Centers, and others. Hospitals & Clinics dominate the segment owing to their high patient throughput, integrated multidisciplinary teams, and ability to invest in advanced imaging infrastructure that supports comprehensive breast care pathways from screening to treatment, thereby driving market growth through bulk procurement and routine clinical utilization. Diagnostic Centers rank second, benefiting from specialized focus on imaging services and cost-efficient high-volume operations that cater to outpatient referrals, further expanding the market by improving accessibility to ABUS technology in community-based settings.
North America leads the global Automated Breast Ultrasound Systems (ABUS) Market with the largest share, supported by robust breast density notification laws in the United States, high healthcare spending, widespread insurance coverage for supplemental screening, and early adoption of AI-enhanced technologies; the United States dominates within the region through advanced research institutions and presence of key manufacturers driving innovation in 3D imaging. Canada contributes steadily with national screening programs emphasizing dense breast awareness.
Europe maintains strong growth led by Germany, France, and the United Kingdom, where rising breast cancer incidence, favorable reimbursement policies, and focus on women’s health initiatives accelerate ABUS integration into national screening protocols; regulatory emphasis on radiation-free diagnostics further bolsters demand.
Asia Pacific emerges as the fastest-growing region fueled by increasing healthcare investments, large patient pools in China and India, and government-backed cancer awareness campaigns; China leads with rapid expansion of hospital infrastructure and local manufacturing partnerships, while Japan and South Korea advance through technological sophistication in diagnostic imaging.
Latin America and the Middle East & Africa represent emerging opportunities, with Brazil and South Africa showing potential through improving diagnostic access and international aid programs targeting women’s cancers, although infrastructure gaps and cost barriers currently moderate faster uptake.
Some of the significant players in the global Automated Breast Ultrasound Systems (ABUS) Market include;
By Product Type
By Application
By End-User
By Region
What is Automated Breast Ultrasound Systems (ABUS) Market?
The Automated Breast Ultrasound Systems (ABUS) Market encompasses the global production, distribution, and clinical adoption of operator-independent 3D ultrasound devices used primarily as adjunct tools to mammography for enhanced breast cancer detection, especially in dense breast tissue.
What are the principal factors expected to drive expansion in the Automated Breast Ultrasound Systems (ABUS) Market between 2026 and 2034?
Principal drivers include escalating breast cancer prevalence, mandatory dense breast screening legislation, technological integration of AI for faster diagnostics, and expanding healthcare access in developing regions that prioritize non-invasive early detection methods.
What is the projected market size of the Automated Breast Ultrasound Systems (ABUS) Market from 2026 to 2034?
The market is projected to grow from approximately USD 2.52 Billion in 2025 to USD 10.11 Billion by 2034.
What overall growth rate (CAGR) is the Automated Breast Ultrasound Systems (ABUS) Market predicted to achieve between 2026 and 2034?
The market is predicted to achieve a CAGR of roughly 16.7% between 2026 and 2034, fueled by clinical efficacy, regulatory support, and innovation in imaging technology.
Which geographic region is forecasted to be a leading contributor to the overall Automated Breast Ultrasound Systems (ABUS) Market valuation?
North America is forecasted to be the leading contributor, supported by advanced healthcare infrastructure, dense breast laws, and high adoption rates of supplemental screening technologies.
Who are the top companies dominating and driving the Automated Breast Ultrasound Systems (ABUS) Market forward?
Top companies include GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Hologic Inc., SonoCine Inc., Delphinus Medical Technologies Inc., Canon Medical Systems Corporation, Hitachi Ltd., QT Imaging, Inc., and ALPINION Medical Systems Co. Ltd., which lead through product innovation, AI integration, and global distribution expansion.
What key information or findings can typically be expected from the global Automated Breast Ultrasound Systems (ABUS) Market report?
The report provides comprehensive data on market size, CAGR forecasts, segmental shares, regional analysis, competitive landscape, growth drivers, restraints, recent developments, and strategic recommendations for stakeholders.
What are the various stages in the value chain of the global Automated Breast Ultrasound Systems (ABUS) Market industry?
The value chain includes raw material sourcing and component manufacturing, system assembly and software integration with AI capabilities, regulatory approvals and clinical validation, distribution through medical equipment channels, end-user training and installation, and post-sale maintenance with data analytics services.
How are current market trends and evolving consumer preferences influencing the Automated Breast Ultrasound Systems (ABUS) Market?
Trends toward radiation-free, patient-friendly imaging and preference for personalized screening protocols are boosting demand for ABUS with AI enhancements, driving preference for faster, more accurate diagnostics that empower women’s health decisions.
What regulatory changes or environmental factors are impacting the growth of the Automated Breast Ultrasound Systems (ABUS) Market?
Breast density notification laws and updated screening guidelines in multiple countries are positively impacting growth by mandating supplemental ultrasound, while environmental focus on reducing radiation exposure favors non-ionizing ABUS technology over traditional modalities.
These players adopted different strategies so as to hold major market share in this market. Some of the major players in [keyword] industry includes. [players list]
Based on the [keyword] market analysis, North America is predicted to held the highest share in the [keyword] market during the forecast period.
The statistical data of the top market players of [keyword] industry can be obtained from the company profile section specified in the report. This section incorporates analysis of top player’s operating in the [keyword] industry as well as their last five-year revenue, segmental revenue, product offerings, key strategies adopted, and geographical revenue produced.
The study offers a decisive view on the [keyword] by segmenting the market based on [segment1], [segment2], and region.
The report gives a nitty-gritty assessment of the market by featuring data on various viewpoints that incorporate drivers, restraints, opportunities, and threats. This data can assist stakeholders in making suitable decisions before investing.
The sample for [keyword] market report can be received on-demand from the website as and when required.Direct call services or 24*7 chat support are provided to procure the sample report.
1.1 Research Methodology
The process of market research at Syndicate Market Research is an iterative in nature and usually follows following path. Information from secondary is used to build data models, further the results obtained from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new information is again incorporated into data model. The process continues till desired level of information is not generated.
To calculate the market size, the report considers the revenue generated from the sales of the market providers. The revenue generated from the sales of market is calculated through primary and secondary research. The key players operating in the market across the globe are identified through secondary research and a corresponding detailed analysis of the top vendors in the market is done. The market size calculation also includes clinical trial phase segmentation determined using secondary sources and verified through primary sources.
1.2 Secondary Research
The secondary research sources that are typically referred to include, but are not limited to:
The sources for secondary research includes but is not limited to: Factiva, Hoovers and Statista
1.3 Primary Research
We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
The participants who typically take part in such a process include, but are not limited to:
1.4 Models
Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data types to produce estimates:
Data is then cross checked by the expert panel.
1.4.1 Company Share Analysis Model
Company share analysis is used to derive the size of global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps:
1.4.2 Revenue Based Modeling
Revenue based models can be built in two ways - Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
1.5 Research Limitations
Inflation is not a part of pricing in this report. Prices of the products and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each type has been taken into account while estimating and forecasting market revenue on a global basis. Regional average price has been considered while breaking down this market by end user in each region.
We focus on the quality and accuracy of the report
Our expert team will assist with all your research needs and customize the report
Get you queries resolved from our expert analysts before and after purchasing the report
Instant delivery in the form of a PDF/PPT/Word Doc to your email address, within 12 hours after receiving the full payment.
Analysts will provide deep insights about the reports
* We value your privacy and will never rent or sell your email address.
Comprehensive & Focused Market Reports Large Archive of Excellent Market and Industry Analysis Reports that Deliver Business Intelligence.
Safe & Secure Payment Solutions
Enabled by SSL, we provide you numerous safe payment options for
risk-free transactions.
Superior Customer Experience We serve our
customers through calls, emails and live chats for 365 days, 24x7.
Syndicate Market Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. Read More
We accept the following payment methods
